Borderline left ventricular hypoplasia without significant aortic or mitral stenosis: cardiac magnetic resonance criteria for biventricular repair
European Journal of Cardio-Thoracic Surgery · 2025
DOI: 10.1093/ejcts/ezaf203 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cardio-Thoracic Surgery, 2025. Verfasst von Aswathy Vaikom House und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Paediatrics, Hospital for Sick Children, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Heart Ventricles, Hypoplastic Left Heart Syndrome, Magnetic Resonance Imaging, Cine, Cardiac Surgical Procedures. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVES Bi-ventricular (Bi-V) repair is viable in some patients with borderline left ventricular (LV) hypoplasia. We aimed to identify cardiovascular magnetic resonance (CMR) criteria predictive of successful primary Bi-V repair in neonates with borderline LV hypoplasia without significant mitral valve (MV) & aortic valve (AV) stenosis. METHODS Retrospective study (2003–2024) of patients with borderline LV hypoplasia with CMR for decision-making. Patients MV stenosis (mean Doppler gradient >5 mmHg) and/or AV stenosis (peak Doppler gradient >20 mmHg) were excluded. Patients were divided into two groups: primary Bi-V repair and hybrid procedure. Outcomes were categorized as successful primary Bi-V repair, successful staged Bi-V repair and failure to achieve Bi-V repair. RESULTS About 23/37 patients (62%) underwent successful primary Bi-V repair, 8/37 (22%) underwent staged Bi-V repair and 6/37 (16%) failed to achieve Bi-V repair. The successful primary/staged Bi-V repair group had higher LVEDVi (P < 0.002), higher blood flow volume through the ascending aorta (P < 0.012) and higher QAo/superior vena cava (QSVC) flow ratio (P = 0.034) compared to the failure to achieve Bi-V repair group. CMR LVEDVi cut-off of 27 ml/m2 had 87% sensitivity and 79% specificity (AUC 87.6%), and QAo threshold of 1.9 l/min/m2 had 65.2% sensitivity and 92.9% specificity (AUC 86.0%) for predicting successful primary Bi-V repair. About 7/31(22%) patients with Bi-V repair underwent reinterventions for LVOT obstruction & MV stenosis. CONCLUSIONS In patients with borderline LV hypoplasia without MV/AV stenosis, CMR LVEDVi > 27 ml/m2 & QAo > 1.99 l/min/m2 were prognostic for successful primary biventricular repair.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiology, Department of Paediatrics, Hospital for Sick Children, Toronto, Ontario, Canada.
- Division of Cardiovascular Surgery, Department of Surgery, Hospital for Sick Children, Toronto, Ontario, Canada.
- Department of Diagnostic & Interventional Radiology, Hospital for Sick Children, Toronto, Ontario, Canada.
ORCID-Profile: Aswathy Vaikom House, David J Barron, Christopher Z Lam, Shi-Joon Yoo
Zitieren
APA
Vaikom House, A., Singh, A., Sapruangrang, A., Jaeggi, E., Barron, D. J., Lam, C. Z., & Yoo, S. J. (2025). Borderline left ventricular hypoplasia without significant aortic or mitral stenosis: cardiac magnetic resonance criteria for biventricular repair. European Journal of Cardio-Thoracic Surgery. https://doi.org/10.1093/ejcts/ezaf203
Vancouver
Vaikom House A, Singh A, Sapruangrang A, Jaeggi E, Barron DJ, Lam CZ, et al. Borderline left ventricular hypoplasia without significant aortic or mitral stenosis: cardiac magnetic resonance criteria for biventricular repair. European Journal of Cardio-Thoracic Surgery. 2025. doi:10.1093/ejcts/ezaf203
BibTeX
@article{VaikomHouse2025,
author = {Vaikom House, Aswathy and Singh, Aakansha and Sapruangrang, Ankavipar and Jaeggi, Edgar and Barron, David J and Lam, Christopher Z and Yoo, Shi-Joon},
title = {Borderline left ventricular hypoplasia without significant aortic or mitral stenosis: cardiac magnetic resonance criteria for biventricular repair},
journal = {European Journal of Cardio-Thoracic Surgery},
year = {2025},
doi = {10.1093/ejcts/ezaf203}
}
EUVIMED